Queerty on MSN5d
A once-a-year PrEP injection? The results of the first clinical trial look promising
Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...
Gilead plots trial of groundbreaking, once-a-year HIV prevention drug lenacapavir
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
BBC8d
Annual jab for HIV protection passes trial hurdle
PrEP tablets are highly effective but taking them every day can be difficult. About 39.9 million people are living with HIV, 65% of them in the World Health Organization African Region ...
standardmedia.co.ke4y
New dawn for HIV and Aids
1. The vaginal ring Use of oral pre-exposure prophylaxis (PrEp) tablets, the female condom and safe sex practices have for decades been the only options for protecting women and girls from the ...
Quebec becomes first province to publicly reimburse APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP)
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi ...